Raj Tummala, based in Gaithersburg, MD, US, is currently a Global Product Leader - Brazikumab ( anti-IL23 mAB) for Crohn's disease and ulcerative colitis at AstraZeneca, bringing experience from previous roles at AstraZeneca. Raj Tummala holds a 2001 - 2002 Fellowship in Clinical Neuropsychopharmacology @ Rush University. With a robust skill set that includes Clinical Research, Clinical Development, Clinical Trials, Oncology, FDA and more, Raj Tummala contributes valuable insights to the industry. Raj Tummala has 3 emails and 1 mobile phone number on RocketReach.